News

The committee reviewed comprehensive data primarily from the Triton TIMI-38 clinical trial. Results from the Triton trial showed that prasugrel taken with aspirin reduced the relative risk of

The Urief tablet is a new formulation of Urief capsule 2mg and Urief capsule 4mg, which were jointly marketed by Daiichi Sankyo and Kissei in Japan since 2006.

During the course of its Phase IIb study an interim analysis was performed and reviewed by an independent data monitoring committee according to ICH guidelines. This analysis was

The assessment was based on clinical trials involving more than 2,600 patients, which confirmed the safety and efficacy of Azzalure. This announcement is part of the partnership established

King Pharmaceuticals has reported positive results from its Phase III 12-month open-label safety and efficacy study evaluating Embeda extended release capsules. The results showed that Embeda provided continued

For the fourth quarter ended December 31, 2008, Sangamo reported a consolidated net loss of $2.6 million, or $0.06 per share, against a net loss of $6.7 million,

Pfizer has discontinued a Phase III study of its investigational agent axitinib for the treatment of advanced pancreatic cancer. Based on an interim analysis, an independent Data Safety

RSDecon, a business of Bracco Diagnostics, and Counter Terrorism Solutions have received approval for the importation and use of RSDL chemical warfare agent skin decontamination lotion from the

Roche has announced that it intends to commence a cash tender offer for all outstanding publicly held shares of Genentech at $86.50 per share. Roche, which currently owns